Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001348362-25-000018
Filing Date
2025-12-19
Accepted
2025-12-18 18:04:53
Documents
1
Effectiveness Date
2025-12-19
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11685
  Complete submission text file 0001348362-25-000018.txt   13054
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: D | Act: 33 | File No.: 021-567444 | Film No.: 251584478
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)